Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.

Tchitchek N, Rosenzwajg M, Lorenzon R, Rinchai D, Chaussabel D, Malek TR, Klatzmann D

DOI: 10.1016/j.ard.2026.07.021
Published: 2026 Aug 19
Container: Annals of the rheumatic diseases
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ard.2026.07.021,
  title = {Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.},
  author = {Tchitchek N and Rosenzwajg M and Lorenzon R and Rinchai D and Chaussabel D and Malek TR and Klatzmann D},
  year = {2026},
  journal = {Annals of the rheumatic diseases},
  doi = {10.1016/j.ard.2026.07.021},
  url = {https://doi.org/10.1016/j.ard.2026.07.021}
}

RIS

TY  - JOUR
TI  - Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.
AU  - Tchitchek N
AU  - Rosenzwajg M
AU  - Lorenzon R
AU  - Rinchai D
AU  - Chaussabel D
AU  - Malek TR
AU  - Klatzmann D
PY  - 2026
JO  - Annals of the rheumatic diseases
DO  - 10.1016/j.ard.2026.07.021
UR  - https://doi.org/10.1016/j.ard.2026.07.021
ER  -

APA

N, T., M, R., R, L., D, R., D, C., TR, M., & D, K. (2026). Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.. Annals of the rheumatic diseases. https://doi.org/10.1016/j.ard.2026.07.021

Source records

pubmed · retrieved 2026-09-26T15:11:42.596Z
europe-pmc · retrieved 2026-09-26T15:11:42.596Z